BioCentury | Nov 30, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: November 2017

...University of California San Diego Distillery Therapeutics Succinate-CoA ligase ADP-forming β subunit (SUCLA2) Liver cancer BicC family RNA binding protein 1...
BioCentury | Nov 27, 2017
Distillery Therapeutics

Cancer

...in models of liver cancer. TARGET/MARKER/PATHWAY: Phosphodiesterase 3A, bGMP-inhibited (PDE3A); FYN binding protein 1 (FYB1); BicC family RNA binding protein 1...
...Jiayi Wang, Tongji University, Shanghai, China email: karajan2@163.com Hongjiang Li Shanghai Jiao Tong University School of Medicine Tongji University BicC family RNA binding protein 1...
Items per page:
1 - 2 of 2